Incidence:  An estimated 20 million people in the United States have some form of peripheral neuropathy, a condition that develops as a result of damage to the peripheral nervous system — the vast communications network that transmits information between the central nervous system (the brain and spinal cord) and every other part of the body.  

 Peripheral Neuropathy Fact sheet

Medical Cannabis Indication:     Neuropathies

          Improves: Neuropathic Pain, Quality of sleep, Muscle Relaxation,

                            Paresthesia (pins and needles), Paresis (weakness),

                            Hypoesthesia (numbness), Paralysis (loss of ability to move)

                           Muscle wasting, Loss of reflexes, Depression

          Causes:   Injury

                          Infection – Shingles, Guillan-Barre Syndrome, Lyme, Chimical Injury

                                             Radiation, Herpes, Leprosy, Leprosy

                         Underlying Condition - Diabetes, Diphtheria    

Recommended cannabinoid ratios:                  

                     equal ratio THC: CBD (e.g. 1:1) 

                     high THC : low CBD (e.g. 20:1)

Dosing:  

Go slow and start dosing low and titrate until desired results are achieved.

 (Combination of  the above products may be required).  THC doses greater than 10mg/dose not recommended

Cannabinoid are modestly as effective and safer than Codeine. 

               5-10mg of THC is as effective as 60mg of Codeine

Other:  

Neuroprotective properties may slow progression of disease.

Cannabinoid replacement therapy may reduce symptoms and prolong survival. 

(Please note that cannabinoid therapy is patient specific and may require dose/concentration adjustment. Please consult with your provider for appropriate therapy options.)

References: 

Journal Articles:  

Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (Abstract)